Skip to content

Clinical trials

Phase 3 Autism Spectrum Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 3 Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20102
20112
20132
20151
20172
20185
20192
20202
20212
20222
20232
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated6
Not yet recruiting3
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital5
The University of Hong Kong4
AbbVie2
Bristol-Myers Squibb2
Institut de Recherches Internationales Servier2
Neurim Pharmaceuticals Ltd.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Seaside Therapeutics, Inc.2
Assaf-Harofeh Medical Center1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder35
Autistic Disorder16
Child Development Disorders, Pervasive3
Asperger Syndrome2
Marijuana Abuse2
Parasomnias2
Schizophrenia2
Sleep Wake Disorders2
Angelman Syndrome1
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.